Shamburg News · 8-K filed Nov 10, 2026, 5:20 PM EST

Lakewood-Amedex Completes Redemption of All Series C Convertible Preferred Stock

LABT · Lakewood-Amedex Biotherapeutics Inc.

  • Material agreement
  • Other event
  • Materiality: medium

On November 4, 2026, Lakewood-Amedex Biotherapeutics Inc. redeemed all 127,097 outstanding shares of its Series C Convertible Preferred Stock from Shakawe Capital LLC under a redemption agreement dated November 2, 2026. The aggregate cash redemption price was $1,270,970, equal to $10.00 per share. The company announced completion of the redemption in a press release dated November 5, 2026, stating that no preferred shares remain outstanding.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 1.01, 7.01, 9.01, accession 0001213900-26-118127.

Written from the filing by Shamburg Markets. Figures are as reported by the company.